In our 100th success video, CPESN® Utah Managing Network Facilitator, Benjamin Jolley, pharmacist with Jolley's Compounding Pharmacy in Salt Lake City, shares a unique success story about pharmacists becoming recognized as Medicaid providers and a new budgeted mandate in Utah directing that state's Medicaid program to pay pharmacists billing under CPT codes for Medication Therapy Management.

Roger Paganelli, CPESN USA Luminary and CPESN NYC pharmacist and coowner of Mt. Carmel Pharmacy in the Bronx, describes how two Bronx pharmacies will raise patient awareness about clinical trial opportunities, focusing particularly on health equity in underserved populations. The opportunity is part of a CPESN® USA national contract with Inside Edge Consulting, a company working with pharmaceutical sponsors of clinical drug trials. (4:45).

Martha Mosher, pharmacist and owner of the El Paso Medicine Shoppe, credits CPESN® Texas and its partnership with the University of Texas for preparing her pharmacy to offer its first clinical program - Diabetes Self Management Education.

RxE2 CEO Gerald Finken shares his perspective on community-based pharmacies being ideal for recruiting and managing medications for patients on clinical trials, while adding a revenue stream for their pharmacy practices (5:15).

Renee Price describes a Medication Therapy Management program with a statewide managed Medicaid program where network pharmacies worked with care managers to improve patient health conditions. The program started with 5 to 10 pilot stores in Kansas, and added two to three pharmacies monthly.

Under renewal of this contract with a Medicare Advantage Plan, 58 CPESN Mississippi pharmacies provide diabetes monitoring and management including A1c testing to establish a base level, counseling to help patients with an A1c >9, bring it under 9%, and make referrals for annual retinal eye exams.

Under this Year 5 program renewal with a national payer, CPESN Wyoming pharmacies provide enhanced Medication Therapy Management and safety reviews for Medicare Part D patients at high risk for adverse drug events. The goal is to demonstrate a positive impact on medical spend directly tied to pharmacist interventions.

In this contract with a statewide Medicaid MCO, Pennsylvania Pharmacist Care Network pharmacists identify gaps in care and address medication adherence for plan-identified patients with COPD and diabetes.

More than half of CPESN Virginia's pharmacies had patients eligible for diabetes managment care under a contract with a large national managed health plan. Services include HbA1c monitoring and a focus on nutrition, motivational interviewing, med management, and care coordination.

A CPESN Ohio network-wide contract with a national MCO focuses on increasing flu vaccination rates, year-over-year.